Spikevax 2025-2026 vaccine, 0.25 mL Prefilled Syringe, 6m through 11y
RxNorm 2722435 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Spikevax 2025-2026 vaccine, 0.25 mL Prefilled Syringe, 6m through 11y (RxCUI 2722435). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Moderna US, Inc. 4

Moderna US, Inc.

NDC Product

Spikevax
NDC 80777-110

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Active Listing
NDC Product

Spikevax
NDC 80777-111

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Vaccine

Spikevax
NDC 80777-112

Generic Name
Covid-19 Vaccine, Mrna
Dosage Form
Injection, Suspension
Route
Intramuscular
Marketing
BLA
Active Listing
NDC Product
Vaccine

Spikevax
NDC 80777-113

Generic Name
Covid-19 Vaccine, Mrna
Dosage Form
Injection, Suspension
Route
Intramuscular
Marketing
BLA
Active Listing